Evidence map›Paper›PMID 30343718›Full record

ReviewAmerican journal of kidney diseases : the official journal of the National Kidney Foundation2018

Genetic Basis of Health Disparity in Childhood Nephrotic Syndrome.

Jennifer D Varner, Ayo Matory, Rasheed A Gbadegesin

Abstract readReview
In one paragraph

Review in American journal of kidney diseases : the official journal of the National Kidney Foundation, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 1 pooled it
1.4field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 1 synthesis or guideline pooled it, 13 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Jennifer D VarnerDuke Molecular Physiology Institute, Duke University Medical Center, Durham, NC; Duke University School of Medicine, Durham, NC.
Ayo MatoryDuke Molecular Physiology Institute, Duke University Medical Center, Durham, NC.
Rasheed A GbadegesinDuke Molecular Physiology Institute, Duke University Medical Center, Durham, NC; Duke University School of Medicine, Durham, NC; Division of Nephrology, Department of Pediatrics, Duke University Medical Center, Durham, NC. Electronic address: rasheed.gbadegesin@duke.edu.
Duke Medical Center · USDuke University · US

Funding

Gene Discovery in Autosomal Dominant Focal Segmental GlomerulosclerosisR01DK094987 · NIDDK · DUKE UNIVERSITY · PI GBADEGESIN, RASHEED ADEBAYO · 2012 to 2016
$2.5M
Functional and Phenotypic Characterization of a New FSGS GeneR01DK098135 · NIDDK · DUKE UNIVERSITY · PI GBADEGESIN, RASHEED ADEBAYO · 2014 to 2018
$1.8M
NIDDK NIH HHS R01 DK094987NIDDK NIH HHS R01 DK098135
6 · The paper itself

Abstract

Nephrotic syndrome is the most common glomerular disease in children. There is wide variation in the incidence of nephrotic syndrome in different populations, with a higher incidence in children of South Asian descent. However, nephrotic syndrome with a more indolent course and poor prognosis is more common in African American children. The disparity in the prevalence and severity of nephrotic syndrome is likely due to complex interactions between environmental and biological factors. Recent advances in genome science are providing insight into some of the biological factors that may explain these disparities. For example, risk alleles in the gene encoding apolipoprotein L1 (APOL1) have been established as the most important factor in the high incidence of chronic glomerular diseases in African Americans. Conversely, the locus for childhood steroid-sensitive nephrotic syndrome in the gene encoding major histocompatibility complex-class II-DQ-alpha 1 (HLA-DQA1) is unlikely to be the explanation for the high incidence of steroid-sensitive nephrotic syndrome in Asian children because the same variants are equally common in whites and African Americans. There is a need for collaborative large-scale studies to identify additional risk loci to explain disparities in disease incidence and response to therapy. Findings from such studies have the potential to lead to the identification of new therapeutic targets for nephrotic syndrome.

Indexed as

Genetic Predisposition to DiseaseHealth StatusRisk AssessmentAllelesApolipoprotein L1ChildGenotypeGlobal HealthHLA-DQ alpha-ChainsHumansIncidenceNephrotic SyndromePrognosisAPOL1 protein, humanApolipoprotein L1HLA-DQA1 antigenHLA-DQ alpha-ChainsAfrican AmericanallelesAPOL1apolipoprotein L1 (APOL1)biological factorschildhoodgeneticshealth disparitiesHLA-DQA1Nephrotic syndromepediatricrace/ethnicityreview

Identifiers

PMID30343718
PMCPMC7077932
OpenAlexW2896284541

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.